Epilepsy

Epilepsy Therapeutics Market Report 2021-2031

Fri, 21 Oct 2022 14:50:56 +0000

As governments in emerging countries are taking measures to improve healthcare, it is positively impacting the anti-epileptic drugs market growth....

$4,479.00

Epileptic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Wed, 13 Jul 2022 12:37:01 +0000

Summary

Epileptic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Epileptic Encephalopathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Epileptic Encephalopathy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Markets Direct’s proprietary d...

$2,000.00

Childhood Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

Tue, 12 Jul 2022 14:45:37 +0000

Summary

Childhood Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Childhood Epilepsy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Childhood Epilepsy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/...

$2,000.00

Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fri, 08 Apr 2022 11:35:28 +0000

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape.

Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the brain which causes seizures. This leads to brief disruptions of the senses and short periods of unconsciousness or convulsions. Symptoms of epilepsy are repeated seizures, weakness, and anxiety, loss of consciousness and contraction, or jerking, of body muscles. Main causes of epilepsy include low oxygen during birth, head injuries that occur during birth or from accidents during youth or adulthood, brain tumors, genetic conditions that result in brain injury, such as tuberous sclerosis, infections such as meningitis or encephalitis, and stroke or any other type of damage to the brain.

Report Highlights

Global Markets Direct's Pharmaceu...

$2,500.00

Epilepsy - Global Clinical Trials Review, H2, 2021

Fri, 03 Sep 2021 16:07:52 +0000

Summary

GlobalData's clinical trial report, “Epilepsy - Global Clinical Trials Review, H2, 2021" provides an overview of Epilepsy Clinical trials scenario. This report provides top line data relating to the clinical trials on Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note:...

$2,500.00

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H1, 2020

Mon, 24 Feb 2020 15:56:48 +0000

Summary

GlobalData's clinical trial report, “Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H1, 2020" provides an overview of Treatment Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Clinical trials scenario. This report provides top line data relating to the clinical trials on Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
...

$2,500.00

Partial Epilepsy Market Insights, Epidemiology and Market Forecast- 2028

Wed, 13 Nov 2019 11:03:24 +0000

DelveInsight's “Partial Epilepsy - Market Insights, Epidemiology and Market Forecast – 2028” report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology. It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market revenue, sales trends, and drug uptake during the study period from 2017-2028. Markets Covered • United States • EU5 (Germany, France, Italy, Spain and the United Kingdom) • Japan Study Period: 2017-2028 Partial Epilepsy Understanding and Treatment Algorithm The report provides the in depth analysis of the disease overview by providing details such as disease definition, classification, symptoms, etiology, pathophysiology and diagnostic trends. The comprehensive details about treatment algorithms and treatment guidelines for Partial Epilepsy in the US, Europe, and Japan are also provided in the report. Partial Epilepsy Epidemiology This section provide the insights about histori...

$6,250.00

Epilepsy - Market Insights, Epidemiology and Market Forecast-2023

Tue, 25 Apr 2017 20:08:12 +0000

Note*: This report requires 7-10 business days to complete. DelveInsight’s Epilepsy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Epilepsy forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Epilepsy till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Epilepsy market. • Identifying patient populations in the global “Epilepsymarket to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the best opportunities for Epilepsy therapeutics in each of the markets covered. • To understand the future market competition in the g...

$4,950.00

Lennox Gastaut Syndrome-Market Insights, Epidemiology and Market Forecast-2023

Wed, 24 Aug 2016 13:19:26 +0000

Note*: This report requires 7-10 business days to complete. DelveInsight’s Lennox Gastaut Syndrome - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Lennox Gastaut Syndrome for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Lennox Gastaut Syndrome forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Lennox Gastaut Syndrome till 2023. Key Coverage and Benefits • The report will help in developing business strategies by understanding the trends shaping and driving the global Lennox Gastaut Syndrome market. • Identifying patient populations in the global “Lennox Gastaut Syndrome market to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the best opportunities for Lennox Gastaut Syndr...

$4,950.00

Epilepsy - Pipeline Review, H1 2016

Thu, 02 Jun 2016 09:19:17 +0000

Summary

Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2016’, provides an overview of the Epilepsy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Epilepsy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured pres...

$2,000.00